Mr. George Wentworth reports

DELPHX ANNOUNCES GRANT OF STOCK OPTIONS

Delphx Capital Markets Inc.'s board of directors has approved the grant of 1.45 million stock options to eligible participants under its stock option plan. The options have a two-year maturity and are exercisable for common shares of Delphx at an exercise price of eight cents per common share, all in accordance with the plan. Of the options granted, 700,000 options were granted to insiders of Delphx, including members of the board and executive officers.

About Delphx Capital Markets Inc.

Delphx is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special-purpose vehicle, Quantem LLC, the company enables broker dealers to offer new private placement securities, providing both fixed-income and cryptocurrency-based solutions. Delphx's proprietary securities include:

• Collateralized put options (CPOs), which provide secured protection against rating downgrades of corporate bonds and/or losses in cryptocurrency holdings;
• Collateralized reference notes (CRNs), which enable investors to assume capped downgrade or cryptocurrency-loss exposure in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by U.S. Bank. These instruments are proprietary products created and owned by Delphx Capital Markets.

We seek Safe Harbor.